Home Infusion Therapy Leader Acquires CarePoint

BioScrip, recently announced the completion of its acquisition of CarePoint Partners.  With 30 years of infusion therapy expertise, BioScrip's coverage area encompasses 46 states, including 40 specialty infusion pharmacies, and 33 nursing locations.  The BioScrip and CarePoint consolidation will provide home infusion services to over 100,000 patients annually.
The home infusion industry has experienced healthy growth over the past few years and is estimated at $9-11B, according to Russell Bodoff, president and CEO of the National Home Infusion Association.  Since 2011, the industry has seen M&A activity resulting in the acquisition of Crescent Healthcare by Walgreens; Pediatric Health Choices's home infusion, enteral divisions acquired by CarePoint.  >>Read more

Infusion Therapy Provider Capitalizes on Growing Market

© Kulty Stock Free Images

Medical Specialties Distributors (MSD), supplier of infusion therapy products and supplies sees a bright future.  With the infusion therapy industry predicted to grow 50% by 2019*, MSD strengthened its position with the recent acquisition of Medical Technology Resources (MTR).  MTR specializes in drug-delivery technology and the billing of infusion products to healthcare providers.   

 "MTR's unique offerings and strong presence in the Midwest enhances our leadership position in the growing home infusion and oncology markets," said James Beck, president and CEO, MSD.  "Over the past three years, we have grown our national footprint through partnerships with multi-site health care providers and strategic relationships with leading manufacturers.  This acquisition is one more step toward our goal of creating a stronger growth platform for MSD.

In 2010, MSD partnered with Water Street Healthcare Partners, a private equity firm that focuses exclusively on the healthcare market.

The U.S. market for infusion therapy devices was valued at just under $1.5 billion in 2012, a 3.2% increase over 2011*. The market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs).  Spurring growth is NLCs and disposable ambulatory infusion pumps (as the number of alternate infusion therapy sites increase).  >>Read more 

* RnR Market Research

AxelaCare Finds Harvest Home

© Dreamstime Stock Photos

Founded in 2008, AxelaCare has been on a quick pace to becoming one of the country’s leading home infusion therapy providers.  Therapies provided range from immune globulin (IG) therapy to antibiotics and nutrition therapy.  Investment from Excellere Partners in 2010 aided AxelaCare’s innovation and tremendous growth - 30-40% per year.

AxelaCare’s management team and New York-based Harvest Partners, LP recently completed the acquisition of the company from Excellere.  Harvest’s senior managing director, Ira Kleinman noting, 

“The company’s [AxelaCare] investment in processes, technology and people has led to an efficient, scaleable model with opportunity for continued growth as a larger share of the population seeks access to these vital services.”  

Read more